Literature DB >> 28710008

Identifying synthetic lethal targets using CRISPR/Cas9 system.

Jaspreet Kaur Dhanjal1, Navaneethan Radhakrishnan2, Durai Sundar3.   

Abstract

Synthetic lethality occurs when co-occurrence of two genetic events is unfavorable for the survival of the cell or organism. The conventional approach of high throughput screening of synthetic lethal targets using chemical compounds has been replaced by RNAi technology. CRISPR/Cas9, an RNA guided endonuclease system is the most recent technology for this work. Here, we have discussed the major considerations involved in designing a CRISPR/Cas9 based screening experiment for identification of synthetic lethal targets. It mainly includes CRISPR library to be used, cell types for conducting the experiment, the most appropriate screening strategy and ways of selecting the desired phenotypes from the complete cell population. The complete knockdown of genes can be achieved using CRISPR/Cas9 knockout libraries. For higher quality loss-of-function screens, haploid cells with defective homology-directed DNA repair mechanism could be used. Two widely used screening formats include arrayed and pooled screens followed by negative or positive selection of the cells with desired phenotype. However, pooled screening format with negative selection of cells serves the best. The advantages of using CRISPR/Cas9 system over the other RNAi approaches have also been discussed. Finally, some studies using CRISPR/Cas9 for genome-wide knockout screening in human cells and computational approaches for identification of synthetic lethal interactions have been discussed.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arrayed screen; CRISPR/Cas9; Knockout library; Pooled screen; Synthetic lethality

Mesh:

Substances:

Year:  2017        PMID: 28710008     DOI: 10.1016/j.ymeth.2017.07.007

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  11 in total

1.  Ezh2-dependent therapies in bladder cancer: synthetic lethality.

Authors:  Cristina Segovia; Jesús M Paramio
Journal:  Ann Transl Med       Date:  2017-12

2.  Computational Approaches for Designing Highly Specific and Efficient sgRNAs.

Authors:  Jaspreet Kaur Dhanjal; Dhvani Vora; Navaneethan Radhakrishnan; Durai Sundar
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Synthetic Vulnerabilities in the KRAS Pathway.

Authors:  Marta Roman; Elizabeth Hwang; E Alejandro Sweet-Cordero
Journal:  Cancers (Basel)       Date:  2022-06-08       Impact factor: 6.575

4.  FAK-targeting PROTAC as a chemical tool for the investigation of non-enzymatic FAK function in mice.

Authors:  Hongying Gao; Chunwei Zheng; Jian Du; Yue Wu; Yonghui Sun; Chunsheng Han; Kehkooi Kee; Yu Rao
Journal:  Protein Cell       Date:  2020-07       Impact factor: 14.870

5.  A chemical approach for global protein knockdown from mice to non-human primates.

Authors:  Xiuyun Sun; Jun Wang; Xia Yao; Wen Zheng; Yang Mao; Tianlong Lan; Liguo Wang; Yonghui Sun; Xinyi Zhang; Qiuye Zhao; Jianguo Zhao; Rui-Ping Xiao; Xiuqin Zhang; Guangju Ji; Yu Rao
Journal:  Cell Discov       Date:  2019-02-05       Impact factor: 10.849

Review 6.  Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation.

Authors:  Win Topatana; Sarun Juengpanich; Shijie Li; Jiasheng Cao; Jiahao Hu; Jiyoung Lee; Kenneth Suliyanto; Diana Ma; Bin Zhang; Mingyu Chen; Xiujun Cai
Journal:  J Hematol Oncol       Date:  2020-09-03       Impact factor: 17.388

7.  CRISPR-cas9 Screening Identified Lethal Genes Enriched in Cell Cycle Pathway and of Prognosis Significance in Breast Cancer.

Authors:  Xi Sun; Zheng Wang; Xiaosong Chen; Kunwei Shen
Journal:  Front Cell Dev Biol       Date:  2021-03-19

Review 8.  To Discover the Efficient and Novel Drug Targets in Human Cancers Using CRISPR/Cas Screening and Databases.

Authors:  Iichiroh Onishi; Kouhei Yamamoto; Yuko Kinowaki; Masanobu Kitagawa; Morito Kurata
Journal:  Int J Mol Sci       Date:  2021-11-15       Impact factor: 5.923

9.  Merkel cell polyomavirus activates LSD1-mediated blockade of non-canonical BAF to regulate transformation and tumorigenesis.

Authors:  Donglim Esther Park; Jingwei Cheng; John P McGrath; Matthew Y Lim; Camille Cushman; Selene K Swanson; Michelle L Tillgren; Joao A Paulo; Prafulla C Gokhale; Laurence Florens; Michael P Washburn; Patrick Trojer; James A DeCaprio
Journal:  Nat Cell Biol       Date:  2020-04-13       Impact factor: 28.824

Review 10.  Inhibition of DNA Repair in Cancer Therapy: Toward a Multi-Target Approach.

Authors:  Samuele Lodovichi; Tiziana Cervelli; Achille Pellicioli; Alvaro Galli
Journal:  Int J Mol Sci       Date:  2020-09-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.